Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.630
+0.010 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cyclo Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cyclo Therapeutics stock have an average target of 0.95, which predicts an increase of 50.79% from the current stock price of 0.63.
Analyst Consensus: Buy
* Price targets were last updated on Aug 26, 2024.
Analyst Ratings
The average analyst rating for CYTH stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 27, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $2.6 → $0.95 | Strong Buy | Maintains | $2.6 → $0.95 | +50.79% | Aug 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $3 → $0.95 | Strong Buy → Hold | Downgrades | $3 → $0.95 | +50.79% | Aug 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +376.19% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +376.19% | May 31, 2024 |
Financial Forecast
Revenue This Year
985.66K
from 1.08M
Decreased by -8.43%
Revenue Next Year
1.23M
from 985.66K
Increased by 24.49%
EPS This Year
-0.69
from -1.23
EPS Next Year
-0.68
from -0.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.3M | 1.9M | 30.0M |
| Avg | 985,657 | 1.2M | 14.8M |
| Low | 560,560 | 496,860 | 511,560 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 17.1% | 92.1% | 2,342.6% |
| Avg | -8.4% | 24.5% | 1,108.1% |
| Low | -47.9% | -49.6% | -58.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.62 | -0.53 | -0.14 |
| Avg | -0.69 | -0.68 | -0.37 |
| Low | -0.75 | -0.81 | -0.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.